A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)

被引：0
|
作者：
Gordon, Leo I. [1 ]
Hong, Fanxing [2 ]
Fisher, Richard I. [3 ]
Bartlett, Nancy L. [4 ]
Connors, Joseph M. [5 ]
Gascoyne, Randy D.
Wagner, Henry [6 ]
Stiff, Patrick J. [7 ]
Cheson, Bruce D. [8 ]
Gospodarowicz, Mary [9 ]
Advani, Ranjana [10 ]
Kahl, Brad [11 ]
Friedberg, Jonathan W. [12 ]
Blum, Kristie A. [13 ]
Habermann, Thomas M. [14 ]
Tuscano, Joseph [15 ]
Hoppe, Richard [16 ]
Horning, Sandra J. [17 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] British Columbia Canc Agcy, Vancouver Clin, Vancouver, BC V5Z 4E6, Canada
[6] Penn State Canc Inst, Hershey, PA USA
[7] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[8] Georgetown Univ Hosp, Div Hematol & Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[9] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[10] Stanford Univ, Dept Med Onc, Stanford, CA 94305 USA
[11] Univ Wisconsin, Madison, WI USA
[12] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
[13] Ohio State Univ, Columbus, OH 43210 USA
[14] Mayo Clin, Rochester, MN USA
[15] UC Davis Canc Ctr, Sacramento, CA USA
[16] Stanford Univ, Palo Alto, CA 94304 USA
[17] Genentech Inc, Clin Dev Hem Onc, San Francisco, CA 94080 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 25 条
  • [1] Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
    Gordon, Leo I.
    Hong, Fangxin
    Fisher, Richard I.
    Bartlett, Nancy L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Gospodarowicz, Mary
    Advani, Ranjana
    Kahl, Brad S.
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph M.
    Hoppe, Richard T.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 684 - 691
  • [2] EFFICACY AND TOLERABILITY OF ABVD AND STANFORD V FOR ELDERLY ADVANCED-STAGE HODGKIN LYMPHOMA (HL): ANALYSIS FROM THE PHASE III RANDOMIZED US INTERGROUP TRIAL E2496
    Evens, A. M.
    Hong, F.
    Gordon, L. I.
    Fisher, R. I.
    Bartlett, N.
    Connors, J. M.
    Wagner, H.
    Gospodarowicz, M.
    Cheson, B. D.
    Advani, R.
    Kahl, B. S.
    Hoppe, R. T.
    Horning, S. J.
    ANNALS OF ONCOLOGY, 2011, 22 : 117 - 118
  • [3] Efficacy and tolerability of ABVD and Stanford V for elderly advanced-stage Hodgkin lymphoma (HL): Analysis from the phase III randomized US Intergroup Trial E2496
    Evens, A. M.
    Hong, F.
    Gordon, L. I.
    Fisher, R. I.
    Bartlett, N.
    Connors, J. M.
    Wagner, H.
    Gospodarowicz, M. K.
    Cheson, B. D.
    Advani, R.
    Kahl, B. S.
    Hoppe, R. T.
    Horning, S. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial
    Advani, Ranjana H.
    Hong, Fangxin
    Fisher, Richard I.
    Bartlett, Nancy L.
    Robinson, K. Sue
    Gascoyne, Randy D.
    Wagner, Henry, Jr.
    Stiff, Patrick J.
    Cheson, Bruce D.
    Stewart, Douglas A.
    Gordon, Leo I.
    Kahl, Brad S.
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph M.
    Hoppe, Richard T.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1936 - U111
  • [5] Randomized Phase III Trial Comparing ABVD plus Radiotherapy and the Stanford V.Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A-Subset Analysis of the US Intergroup Trial E2496
    Advani, Ranjana
    Hong, Fangxin
    Fisher, Richard I.
    Bartlett, Nancy L.
    Robinson, Sue
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Stewart, Douglas A.
    Gordon, Leo I.
    Kahl, Brad
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Hoppe, Richard
    Horning, Sandra J.
    BLOOD, 2010, 116 (21) : 185 - 186
  • [6] Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD plus Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496
    Advani, Ranjana
    Hong, Fangxin
    Gordon, Leo I.
    Gascoyne, Randy D.
    Wagner, Henry
    Hoppe, Richard T.
    Fisher, Richard I.
    Bartlett, Nancy L.
    Kahl, Brad S.
    Stiff, Patrick
    Cheson, Bruce D.
    Belch, Andrew R.
    Friedberg, Jonathan W.
    Kassis, Jeannine
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Horning, Sandra J.
    BLOOD, 2011, 118 (21) : 696 - 697
  • [7] Tumor-Associated Macrophages Predict Inferior Outcomes in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma - A Correlative Study from the E2496 Intergroup Trial
    Tan, K. L.
    Scott, D. W.
    Hong, F.
    Horning, S. J.
    Fisher, R. I.
    Bartlett, N. L.
    Shepherd, L. E.
    Connors, J. M.
    Kahl, B. S.
    Gordon, L. I.
    Steidl, C.
    Gascoyne, R. D.
    MODERN PATHOLOGY, 2012, 25 : 374A - 375A
  • [8] Tumor-Associated Macrophages Predict Inferior Outcomes in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma - A Correlative Study from the E2496 Intergroup Trial
    Tan, K. L.
    Scott, D. W.
    Hong, F.
    Horning, S. J.
    Fisher, R. I.
    Bartlett, N. L.
    Shepherd, L. E.
    Connors, J. M.
    Kahl, B. S.
    Gordon, L. I.
    Steidl, C.
    Gascoyne, R. D.
    LABORATORY INVESTIGATION, 2012, 92 : 374A - 375A
  • [9] A Gene. Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma - a Correlative Study From the E2496 Intergroup Trial
    Scott, David W.
    Chan, Fong Chun
    Hong, Fangxin
    Rogic, Sanja
    Tan, King
    Meissner, Barbara
    Farinha, Pedro
    Horning, Sandra J.
    Fisher, Richard I.
    Bartlett, Nancy L.
    Shepherd, Lois E.
    Connors, Joseph M.
    de Sousa, Aida B.
    Kahl, Brad S.
    Gordon, Leo I.
    Steidl, Christian
    Gascoyne, Randy D.
    BLOOD, 2011, 118 (21) : 198 - 199
  • [10] ABVD vs. STANFORD V (SV) vs. MOPP-EBV-CAD (MEC) in advanced Hodgkin's lymphoma. Final results of the IIL HD9601 randomized trial.
    Federico, M
    Levis, A
    Luminari, S
    Chisesi, T
    Marcheselli, L
    Goldaniga, M
    Vitolo, U
    Neri, S
    Brugiatelli, M
    Gobbi, PG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 559S - 559S
123